- Home
- HRMY vs MANU Comparison
HRMY vs MANU Comparison
Compare HRMY & MANU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- MANU
- Stock Information
- Founded
- HRMY 2017
- MANU 1878
- Country
- HRMY United States
- MANU United Kingdom
- Employees
- HRMY N/A
- MANU N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- MANU Services-Misc. Amusement & Recreation
- Sector
- HRMY Health Care
- MANU Consumer Discretionary
- Exchange
- HRMY Nasdaq
- MANU Nasdaq
- Market Cap
- HRMY 2.0B
- MANU 2.2B
- IPO Year
- HRMY 2020
- MANU 2012
- Fundamental
- Price
- HRMY $31.89
- MANU $17.39
- Analyst Decision
- HRMY Strong Buy
- MANU Buy
- Analyst Count
- HRMY 9
- MANU 2
- Target Price
- HRMY $54.22
- MANU $20.75
- AVG Volume (30 Days)
- HRMY 611.9K
- MANU 342.8K
- Earning Date
- HRMY 08-05-2025
- MANU 06-06-2025
- Dividend Yield
- HRMY N/A
- MANU N/A
- EPS Growth
- HRMY 13.13
- MANU N/A
- EPS
- HRMY 2.62
- MANU N/A
- Revenue
- HRMY $744,852,000.00
- MANU $832,748,485.00
- Revenue This Year
- HRMY $20.10
- MANU $2.44
- Revenue Next Year
- HRMY $18.01
- MANU $3.26
- P/E Ratio
- HRMY $12.17
- MANU N/A
- Revenue Growth
- HRMY 20.62
- MANU N/A
- 52 Week Low
- HRMY $26.47
- MANU $12.05
- 52 Week High
- HRMY $41.61
- MANU $18.42
- Technical
- Relative Strength Index (RSI)
- HRMY 36.85
- MANU 72.42
- Support Level
- HRMY $32.39
- MANU $17.22
- Resistance Level
- HRMY $33.42
- MANU $17.67
- Average True Range (ATR)
- HRMY 1.06
- MANU 0.62
- MACD
- HRMY -0.47
- MANU 0.19
- Stochastic Oscillator
- HRMY 6.91
- MANU 92.76
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About MANU Manchester United Ltd.
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, and sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which the majority of the revenue is generated including Commercial, Broadcasting, and Matchday.